Premier Asset Management LLC Iovance Biotherapeutics, Inc. Transaction History

Premier Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $585,266 - $765,878	-28,760 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $469,650 - $951,093	28,760 New	28,760 $748,000
Q1 2021 May 12, 2021	SELL	$28.67 - $52.59 $199,285 - $365,553	-6,951 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $360,874 - $646,846	-12,870 Reduced 64.93%	6,951 $323,000
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $335,247 - $438,540	12,081 Added 156.09%	19,821 $652,000
Q2 2020 Jul 31, 2020	SELL	$27.21 - $41.0 $96,459 - $145,345	-3,545 Reduced 31.41%	7,740 $212,000
Q1 2020 May 07, 2020	BUY	$19.54 - $38.85 $220,508 - $438,422	11,285 New	11,285 $338,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Premier Asset Management LLC with notifications on news.